Senseonics (NYSE:SENS) Reaches New 12-Month High – Time to Buy?

Senseonics Holdings, Inc. (NYSE:SENS) shares hit a new 52-week high during trading on Tuesday . The company traded as high as $1.20 and last traded at $1.06, with a volume of 18589708 shares changing hands. The stock had previously closed at $1.13.

Analysts Set New Price Targets

A number of brokerages recently commented on SENS. HC Wainwright reiterated a “buy” rating and set a $2.00 price target on shares of Senseonics in a report on Friday, November 15th. StockNews.com assumed coverage on shares of Senseonics in a report on Thursday, December 26th. They issued a “sell” rating on the stock.

Senseonics Stock Down 6.3 %

The company has a debt-to-equity ratio of 59.17, a quick ratio of 2.38 and a current ratio of 2.47. The company’s 50 day moving average price is $0.55 and its 200-day moving average price is $0.43.

Senseonics (NYSE:SENS) last issued its earnings results on Thursday, November 7th. The company reported ($0.04) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.03) by ($0.01). The firm had revenue of $4.26 million during the quarter, compared to the consensus estimate of $4.02 million. Senseonics had a negative net margin of 362.30% and a negative return on equity of 842.25%. Equities analysts forecast that Senseonics Holdings, Inc. will post -0.14 earnings per share for the current fiscal year.

Insider Buying and Selling at Senseonics

In related news, CEO Timothy T. Goodnow bought 315,000 shares of the company’s stock in a transaction on Tuesday, December 10th. The shares were purchased at an average price of $0.31 per share, for a total transaction of $97,650.00. Following the completion of the transaction, the chief executive officer now directly owns 11,310,355 shares in the company, valued at approximately $3,506,210.05. The trade was a 2.86 % increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CFO Frederick T. Sullivan purchased 124,933 shares of Senseonics stock in a transaction dated Thursday, December 12th. The stock was bought at an average price of $0.38 per share, with a total value of $47,474.54. Following the completion of the transaction, the chief financial officer now owns 2,478,844 shares of the company’s stock, valued at $941,960.72. This represents a 5.31 % increase in their position. The disclosure for this purchase can be found here. Insiders own 3.60% of the company’s stock.

Institutional Investors Weigh In On Senseonics

A number of institutional investors and hedge funds have recently modified their holdings of the company. FMR LLC increased its holdings in Senseonics by 48,267.2% during the 3rd quarter. FMR LLC now owns 168,318 shares of the company’s stock worth $59,000 after acquiring an additional 167,970 shares during the period. Ridgecrest Wealth Partners LLC bought a new position in shares of Senseonics in the fourth quarter worth $60,000. GSA Capital Partners LLP purchased a new stake in shares of Senseonics in the third quarter worth $117,000. Symmetry Partners LLC bought a new stake in Senseonics during the third quarter valued at $164,000. Finally, Cubist Systematic Strategies LLC grew its position in Senseonics by 25.9% during the second quarter. Cubist Systematic Strategies LLC now owns 415,404 shares of the company’s stock worth $166,000 after buying an additional 85,501 shares in the last quarter. 12.36% of the stock is owned by hedge funds and other institutional investors.

Senseonics Company Profile

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.